These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9392436)

  • 1. Mathematical theory of competitive binding assays: an exact and practical model.
    Chen QH; Bylund DB
    Recept Signal Transduct; 1997; 7(2):73-84. PubMed ID: 9392436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand dissociation constants from competition binding assays: errors associated with ligand depletion.
    Goldstein A; Barrett RW
    Mol Pharmacol; 1987 Jun; 31(6):603-9. PubMed ID: 3600604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive immunosorbent assays using ligand-enzyme conjugates bifunctional liposomes: theory and experiment.
    Jones MA; Kilpatrick PK; Carbonell RG
    Biotechnol Prog; 1996; 12(4):519-26. PubMed ID: 8987478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple theoretical model for fluorescence polarization binding assay development.
    Nosjean O; Souchaud S; Deniau C; Geneste O; Cauquil N; Boutin JA
    J Biomol Screen; 2006 Dec; 11(8):949-58. PubMed ID: 17092915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the cost and sensitivity of receptor- and enzyme-based assays.
    Model MA; Healy KE
    Anal Biochem; 1999 Jun; 271(1):59-69. PubMed ID: 10361005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioreceptor analysis: the theoretical bases of the method].
    Zaĭtsev SV; Sergeeva MG; Varfolomeev SD
    Bioorg Khim; 1985 Mar; 11(3):370-9. PubMed ID: 4004954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of lateral flow biodetectors: competitive format.
    Qian S; Bau HH
    Anal Biochem; 2004 Mar; 326(2):211-24. PubMed ID: 15003562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of binding curves obtained with high receptor concentrations: practical aid for computer analysis.
    Swillens S
    Mol Pharmacol; 1995 Jun; 47(6):1197-203. PubMed ID: 7603460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
    Albizu L; Teppaz G; Seyer R; Bazin H; Ansanay H; Manning M; Mouillac B; Durroux T
    J Med Chem; 2007 Oct; 50(20):4976-85. PubMed ID: 17850055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of ligand-receptor binding using SPME: investigation of receptor, free, and total ligand concentrations.
    Musteata FM; Pawliszyn J
    J Proteome Res; 2005; 4(3):789-800. PubMed ID: 15952725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2.
    Kanke T; Ishiwata H; Kabeya M; Saka M; Doi T; Hattori Y; Kawabata A; Plevin R
    Br J Pharmacol; 2005 May; 145(2):255-63. PubMed ID: 15765104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro receptor binding assays: general methods and considerations.
    Bigott-Hennkens HM; Dannoon S; Lewis MR; Jurisson SS
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):245-53. PubMed ID: 18475249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder.
    Werling LL; Keller A; Frank JG; Nuwayhid SJ
    Exp Neurol; 2007 Oct; 207(2):248-57. PubMed ID: 17689532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A competitive low-affinity binding model for determining the mutual and specific sites of two ligands on protein.
    Bai G; Cui Y; Yang Y; Ye C; Liu M
    J Pharm Biomed Anal; 2005 Jul; 38(4):588-93. PubMed ID: 15967285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining methods for calculations of binding free energies: LRA, LIE, PDLD-LRA, and PDLD/S-LRA calculations of ligands binding to an HIV protease.
    Sham YY; Chu ZT; Tao H; Warshel A
    Proteins; 2000 Jun; 39(4):393-407. PubMed ID: 10813821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of competition binding assays: assessment of the range of validity of a commonly invoked assumption.
    Chatelier RC
    J Recept Res; 1987; 7(6):871-84. PubMed ID: 3450872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions.
    Handl HL; Vagner J; Yamamura HI; Hruby VJ; Gillies RJ
    Anal Biochem; 2004 Jul; 330(2):242-50. PubMed ID: 15203329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical analysis of the inter-ligand overhauser effect: a new approach for mapping structural relationships of macromolecular ligands.
    London RE
    J Magn Reson; 1999 Dec; 141(2):301-11. PubMed ID: 10579953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.